Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Consumers report glucose meter problems to FDA.

Steven I Gutman1, Janie G Fuller, Ethan D Hausman

  • 1Division of Chemistry and Toxicology Devices, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Rockville, Maryland 20850, USA.

Diabetes Technology & Therapeutics
|February 3, 2005
PubMed
Summary

User reports to the FDA reveal common glucose meter issues like inaccurate readings and calibration problems. These insights help improve glucose monitoring device safety and performance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of FDA Labeling Changes Related to PREA Safety-Waivers.

Therapeutic innovation & regulatory science·2023
Same author

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017
Same author

Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2014
Same author

A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment.

Journal of the National Cancer Institute·2009
Same author

Counterpoint: Food and Drug Administration guidance for C-reactive protein assays: matching claims with performance data.

Clinical chemistry·2006
Same author

Point-of-care biosensor systems for cancer diagnostics/prognostics.

Biosensors & bioelectronics·2006

Area of Science:

  • Medical Devices
  • Diabetes Management
  • Regulatory Science

Background:

  • Glucose meters are crucial for diabetes mellitus management.
  • The U.S. Food and Drug Administration (FDA) monitors adverse events related to medical devices.
  • Surveillance includes reports from healthcare professionals, manufacturers, and individual users.

Purpose of the Study:

  • To analyze user-reported problems with glucose meters submitted to the FDA.
  • To identify common and unique issues encountered by glucose meter users.

Main Methods:

  • Analysis of glucose meter adverse event reports submitted to the FDA.
  • Data collected over a 3-year period (2000-2002).
  • Focus on reports specifically from end-users.

Related Experiment Videos

Main Results:

  • Glucose meters constituted the majority (84%) of in vitro diagnostic device reports.
  • Among user reports, false high/low or erratic values were most frequent.
  • Other issues included incorrect test strips, calibration difficulties, and regulatory misunderstandings.

Conclusions:

  • User reports provide valuable data for the FDA's device surveillance.
  • The FDA encourages continued reporting from users to enhance device safety.